Kovacs Boldizsar, Burri Haran, Buehler Andres, Reek Sven, Sticherling Christian, Schaer Beat, Linka Andre, Ammann Peter, Müller Andreas S, Dzemali Omer, Kobza Richard, Schindler Matthias, Haegeli Laurent, Mayer Kurt, Eriksson Urs, Herrera-Siklody Claudia, Reichlin Tobias, Steffel Jan, Saguner Ardan M, Duru Firat
Department of Cardiology, University Heart Center Zurich, Rämistrasse 100, 8091 Zurich, Switzerland.
Department of Cardiology, University Hospital of Geneva, 1205 Geneva, Switzerland.
J Clin Med. 2021 Aug 25;10(17):3811. doi: 10.3390/jcm10173811.
The wearable cardioverter defibrillator (WCD) uses surface electrodes to detect arrhythmia before initiating a treatment sequence. However, it is also prone to inappropriate detection due to artefacts.
The aim of this study is to assess the alarm burden in patients and its impact on clinical outcomes.
Patients from the nationwide Swiss WCD Registry were included. Clinical characteristics and data were obtained from the WCDs. Arrhythmia recordings ≥30 s in length were analysed and categorized as VT/VF, atrial fibrillation (AF), supraventricular tachycardia (SVT) or artefact.
A total of 10653 device alarms were documented in 324 of 456 patients (71.1%) over a mean WCD wear-time of 2.0 ± 1.6 months. Episode duration was 30 s or more in 2996 alarms (28.2%). One hundred and eleven (3.7%) were VT/VF episodes. The remaining recordings were inappropriate detections (2736 (91%) due to artefacts; 117 (3.7%) AF; 48 (1.6%) SVT). Two-hundred and seven patients (45%) had three or more alarms per month. Obesity was significantly associated with three or more alarms per month ( = 0.01, 27.7% vs. 15.9%). High alarm burden was not associated with a lower average daily wear time (20.8 h vs. 20.7 h, = 0.785) or a decreased implantable cardioverter defibrillator implantation rate after stopping WCD use (48% vs. 47.3%, = 0.156).
In patients using WCDs, alarms emitted by the device and impending inappropriate shocks were frequent and most commonly caused by artefacts. A high alarm burden was associated with obesity but did not lead to a decreased adherence.
可穿戴式心脏复律除颤器(WCD)在启动治疗程序前使用体表电极检测心律失常。然而,它也容易因伪迹而出现不恰当检测。
本研究旨在评估患者的警报负担及其对临床结局的影响。
纳入来自瑞士全国WCD注册中心的患者。从WCD获取临床特征和数据。对长度≥30秒的心律失常记录进行分析,并分类为室性心动过速/心室颤动(VT/VF)、心房颤动(AF)、室上性心动过速(SVT)或伪迹。
456例患者中的324例(71.1%)在平均WCD佩戴时间2.0±1.6个月期间共记录到10653次设备警报。2996次警报(28.2%)的发作持续时间为30秒或更长。111次(3.7%)为VT/VF发作。其余记录为不恰当检测(2736次(91%)因伪迹;117次(3.7%)AF;48次(1.6%)SVT)。207例患者(45%)每月有三次或更多警报。肥胖与每月三次或更多警报显著相关(P = 0.01,27.7%对15.9%)。高警报负担与较低的平均每日佩戴时间无关(20.8小时对20.7小时,P = 0.785),也与停止使用WCD后植入式心脏复律除颤器植入率降低无关(48%对47.3%,P = 0.156)。
在使用WCD的患者中,设备发出的警报和即将出现的不恰当电击很常见,最常见的原因是伪迹。高警报负担与肥胖有关,但并未导致依从性降低。